Skip to main navigation Skip to search Skip to main content

An old idea tackling a new problem: Targeted toxins specific for cancer stem cells

Research output: Contribution to journal › Review article › peer-review

Abstract

Targeting and killing specific cells discriminately has been the goal of targeted therapy dating back to the era of Paul Ehrlich. The discovery of cancer stem cells has caused a paradigm shift within the cancer field and provided an opportunity to use targeted therapies such as targeted toxins to bind and kill these cells selectively. A number of targeted toxins have been developed against recently identified cancer stem cell markers. In this review we discuss the development and current status of these exciting novel drugs and their potential use to combat drug-refractory relapse.

Original languageEnglish (US)
Pages (from-to)82-92
Number of pages11
JournalAntibodies
Volume2
Issue number1
DOIs
StatePublished - Jan 28 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CD123
  • CD133
  • CD44
  • Cancer stem cells
  • EpCAM
  • Immunotoxins
  • Targeted toxins

Fingerprint

Dive into the research topics of 'An old idea tackling a new problem: Targeted toxins specific for cancer stem cells'. Together they form a unique fingerprint.

Cite this